Comprehensive Cancer Center of Wake Forest University Baptist Medical Center

Winston-Salem, North Carolina 27157-1082

0 studies enrolling now · 84 studies all time

What they study most

Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cardiac Toxicity, Cervical Cancer, Childhood Germ Cell Tumor, Chronic Myeloproliferative Disorders, Colorectal Cancer, Diarrhea, Endometrial Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor

Studies at this site

• Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer — Completed
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer — Completed
• Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium — Completed
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer — Completed
• Combination Chemotherapy in Treating Women With Breast Cancer — Completed
• Gemcitabine in Treating Patients With Advanced Colorectal Cancer — Completed
• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer — Completed
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy — Completed
• Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed — Completed
• Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer — Completed
• High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia — Completed
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer — Completed
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease — Completed
• DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia — Completed
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer — Completed
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia — Completed
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
• Topotecan in Treating Patients With Myelodysplastic Syndrome — Completed
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer — Completed
• Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy — Completed
• Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases — Completed
• Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] — Stopped early
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia — Completed
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia — Completed
• Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa — Stopped early
• Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus — Completed
• Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed — Completed
• Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma — Completed
• Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer — Completed
• Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors — Completed
• Talc in Treating Patients With Malignant Pleural Effusion — Completed
• Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma — Completed
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease — Completed
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer — Completed
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer — Completed
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma — Completed
• Brachytherapy in Treating Patients With Prostate Cancer — Completed
• Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer — Completed
• Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases — Completed
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer — Completed
• Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers — Completed
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer — Completed
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus — Stopped early
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer — Completed